Search

everythinglearnresearchcommunity

for

Search:↓

Early treatment with certain drug combinations improved COVID-19 outcomes and prevented severe disease in males, including those at higher risk.

Dutasteride and finasteride have similar risk for osteoporosis and fractures in older men.

Dutasteride reduces hospitalization and prostate cancer risk compared to finasteride, potentially offsetting its higher cost.

A new liposomal system for applying dutasteride to the skin was developed, showing better skin absorption and stability, potentially improving treatment for hair loss.

Dutasteride can reduce night-time urination but it doesn't improve sleep quality.

Genetic variations affect dutasteride treatment response for male pattern hair loss.

Dutasteride may help shrink prostate cancer tumors.

Combining dutasteride injections with oral minoxidil may improve hair regrowth more than using oral minoxidil alone.

The authors suggest that 5-α-reductase inhibitors, like dutasteride, are effective in treating frontal fibrosing alopecia and should be the first-line treatment, with other options for severe cases. They also recommend further research on Janus kinase inhibitors.

Dutasteride for hair loss might increase the risk of a rare stroke type.

Metabolic syndrome reduces effectiveness of hair loss treatment.

Dutasteride is effective for treating prostate enlargement and reducing related surgery risk, but is not approved for preventing prostate cancer.

Finasteride may increase the risk of suicide or severe self-harm in men with mood disorders but not in the general population.

The dutasteride nanoemulsion could improve hair loss treatment by enhancing drug penetration and retention in hair follicles.

Dutasteride, usually used for prostate issues and hair loss, could potentially treat Amyotrophic Lateral Sclerosis (ALS) due to its neuroprotective, antioxidant, and anti-inflammatory properties, but more testing is needed.

Dutasteride is the most effective for hair loss but may cause sexual and mental side effects.

Dutasteride is more effective than finasteride for long-term hair growth in men with androgenic alopecia.

Dutasteride and finasteride can help increase hair growth gene expression but need further improvement.

Dutasteride and finasteride cause kidney damage, with dutasteride being more harmful.

Low input with cover crop optimizes yield and reduces greenhouse gas emissions.

Men with male pattern baldness had worse COVID-19 symptoms, but early treatment with certain drugs improved outcomes for all.

RF-mesotherapy with dutasteride may be a promising alternative treatment for hair loss.

Dutasteride and minoxidil mesotherapy effectively treats hair loss with minimal side effects.

Low-dose finasteride and dutasteride reduce PSA levels by 27.8% in men with male androgenetic alopecia.

Dutasteride more effective than finasteride for hair growth; SM04554 safe and potentially effective for hair loss.

Finasteride and dutasteride may lower melanoma risk, with teenage acne possibly indicating higher risk.

Dutasteride is more effective than Finasteride in reducing prostate size and PSA levels, but both drugs have similar side effects.

Finasteride and dutasteride can increase beard thickness in men.

Dutasteride mesotherapy showed mixed results and is not recommended as a primary treatment for hair loss.

Both treatment combinations improved hair growth similarly and were safe.